Korro Bio (KRRO) Current Leases (2020 - 2026)

Korro Bio (KRRO) has reported Current Leases for 7 consecutive years, with $2.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Leases rose 21.03% year-over-year to $2.9 million; the trailing twelve-month figure through Jun 2026 stood at $2.9 million (up 21.03% YoY), and the FY2025 full-year result was $2.7 million, up 108.1% from the prior year.
• Current Leases climbed to $2.9 million in Q2 2026 per KRRO's latest filing, from $2.8 million in the prior quarter.
• Across five years, Current Leases topped out at $3.1 million in Q3 2025 and bottomed at $457000.0 in Q2 2024.
• Historically, Current Leases has averaged $2.1 million across 5 years, with a median of $2.1 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Current Leases sank 78.87% in 2024, then jumped 430.63% in 2025.
• Over 5 years, Current Leases stood at $2.9 million in 2022, then sank by 31.84% to $2.0 million in 2023, then tumbled by 35.51% to $1.3 million in 2024, then surged by 108.1% to $2.7 million in 2025, then gained by 9.84% to $2.9 million in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $2.9 million, $2.8 million, and $2.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.